Dave Wallace, Generics Bulletin executive editor (@DaveGenerics) header
Dave Wallace, Generics Bulletin executive editor (@DaveGenerics) profile picture

Generics Bulletin editor Dave Wallace looks at everything that's important to the generics, biosimilars and value-added medicines industries. All views my own.

Joined March 2019
Dave Wallace, Generics Bulletin executive editor retweeted
Amgen Delivers On Launch Of First US Humira Rival – At A 55% Discount https://teapawt.org/t.co/fRmAduw6I1
1
144
Dave Wallace, Generics Bulletin executive editor retweeted
Shortlist Unveiled For GGB Awards https://teapawt.org/t.co/cvLlCDiTVB
Dave Wallace, Generics Bulletin executive editor retweeted
In this @Pharma_Intell interview, #AAMBoard Vice Chair Christine Baeder (Senior Vice President, Chief Operating Officer for US Generics @TevaUSA) explores the challenges and opportunities of #ComplexGenerics. Read: generics.pharmaintelligence.…
2
2
Dave Wallace, Generics Bulletin executive editor retweeted
Biosimilars Forum executive director Juliana Reed discusses the Forum's priorities and leadership in the #biosimilars industry in an interview with @DaveGenerics @Genericbulletin Read more here: generics.pharmaintelligence.…
1
1
Dave Wallace, Generics Bulletin executive editor retweeted
This is the first part of an exclusive two-part interview with David Wallace at @Genericbulletin, where I talk about Alvotech’s plans to move forward following the SPAC merger, partnerships, and strategy on our biosimilars journey. https://teapawt.org/t.co/BIdmfAKnZt
1
3
Dave Wallace, Generics Bulletin executive editor retweeted
Thanks for a great night at the #GGBAwards. A big shout out to all the entries for this year’s #CSR Initiative of the Year award. It’s so encouraging to see all the great work the Generics sector is doing to support people in need. @Genericbulletin @DaveGenerics
2
2
Dave Wallace, Generics Bulletin executive editor retweeted
Finally, our last award of the night, sponsored by IQVIA, goes to Celltrion Healthcare (taking home the hat-trick!) for Company of the Year! Well done and congratulations to all of tonight’s winners! #GGBAwards
Dave Wallace, Generics Bulletin executive editor retweeted
We are attending the @GGB_Awards in Milan next week, where we will be presenting the '#CSR Initiative of the Year' award to the company that’s been setting the pace in corporate social responsibility in 2021. We’re looking forward to meeting some of you there!
1
2
Dave Wallace, Generics Bulletin executive editor retweeted
Shortlist Revealed For GGB Awards https://teapawt.org/t.co/JN8yxD8fly
Dave Wallace, Generics Bulletin executive editor retweeted
Biosimilars Players Climb Global Rankings https://teapawt.org/t.co/t1XwFAZBgP
Dave Wallace, Generics Bulletin executive editor retweeted
Ups And Downs See Mid-Table Players Shift Position https://teapawt.org/t.co/uuPPqmitKj
1
1
Dave Wallace, Generics Bulletin executive editor retweeted
Pfizer Takes ‘Opportunistic’ Approach To Future Biosimilars https://teapawt.org/t.co/hUTTGl96Ck
Dave Wallace, Generics Bulletin executive editor retweeted
Watch the launch video of the #IGBA whitepaper 'A Vision for the Global Generic and Biosimilar Medicines Industry' which covers the strong contribution of the #pharmaceutical sector to global health outcomes and economies, Vision 2030, etc. Watch here: https://teapawt.org/t.co/85tQh3WUnK
1
5
2
Dave Wallace, Generics Bulletin executive editor retweeted
Philip Morris Bid For Vectura Trumps Carlyle Takeover https://teapawt.org/t.co/7lWMvghbfI
Dave Wallace, Generics Bulletin executive editor retweeted
Who’s Hired? Accord’s Burt Moves On https://teapawt.org/t.co/yU74ckWyxn
Dave Wallace, Generics Bulletin executive editor retweeted
Lupin Responds To FDA Warning Letter https://teapawt.org/t.co/HUHkrAuBqp
Dave Wallace, Generics Bulletin executive editor retweeted
What’s Next? Five Things To Look Out For In July https://teapawt.org/t.co/qNGtACWsgq
Dave Wallace, Generics Bulletin executive editor retweeted
Indian Leaders Begin Unique Collaboration On Molnupiravir https://teapawt.org/t.co/NjXdgJfVxO
Dave Wallace, Generics Bulletin executive editor retweeted
Read an interview with #AAMboard member Keren Haruvi, President of Sandoz US and Head of North America, @Sandoz_Global. generics.pharmaintelligence.…
1
2
Dave Wallace, Generics Bulletin executive editor retweeted
Sandoz Aims To Be ‘First In And Last Out’ In North America https://teapawt.org/t.co/ijHyEsP99C